Grant Nolan is a seasoned finance professional with extensive experience in corporate accounting and financial management. Currently serving as Corporate Controller at Colossal Biosciences since September 2024, Grant previously held the position of Assistant Controller at Sonata Therapeutics and progressed through various roles at Kiniksa Pharmaceuticals, including Associate Director of Accounting and Senior Manager of Accounting. Early career experience includes significant roles at EY as an Assurance Senior and internships at EMD Shared Services America and NeoSaej, where Grant developed skills in invoice processing, accounts receivable management, and financial statement preparation. Grant holds a Master’s degree in Accounting from Bentley University and a Bachelor of Science in Accounting from the same institution.